Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Lynnette J. Anderson NP

Lynnette J. Anderson NP profile photo picture

APP Mgr Hybrid

Institution: Medical College of Wisconsin
Department: Pediatrics
Division: Hematology and Oncology - Pediatrics
Program: Oncology

View Curriculum Vitae

Publications (16)

  • Perspectives on Virtual Care for Childhood Cancer Survivors in Non-Metropolitan Areas during the COVID-19 Pandemic. (Phelan R, Aremu TO, Karst J, Anderson L, Jordan A, Morin J, Nichols J, Singh A, Schmidt D, Hoag JA, Napurski C, Zweber H, Sadak KT) Curr Oncol 2023 Sep 01;30(9):8111-8116 PMID: 37754503 PMCID: PMC10529011 SCOPUS ID: 2-s2.0-85172665792 09/27/2023       2 Citations
  • Evaluation of a transition to survivorship program for pediatric, adolescent, and young adult cancer patients and caregivers. (Bingen K, Karst J, Anderson L, Chan S, Jordan A, Morin J, Nichols J, Palou-Torres A, Phelan R, Schmidt D, Yan K, Hoag JA) Pediatr Blood Cancer 2023 May;70(5):e30277 PMID: 36880713 SCOPUS ID: 2-s2.0-85150349486 03/08/2023       1 Citation
  • Dexmedetomidine for sedation during hematopoietic stem cell harvest apheresis and leukapheresis in the PICU: Guideline development. (Magner K, Mikhailov T, Simpson P, Anderson L, Buchman B, Gedeit R, Margolis D, Meyer MT) Transfus Apher Sci 2023 Feb;62(1):103525 PMID: 36058778 SCOPUS ID: 2-s2.0-85138530115 09/05/2022    
  • Evaluation of fatigue and related factors in survivors of pediatric cancer and hematopoietic stem cell transplant. (Karst JS, Hoag JA, Anderson LJ, Schmidt DJ, Schroedl RL, Bingen KM) J Child Health Care 2022 Sep;26(3):383-393 PMID: 33913779 SCOPUS ID: 2-s2.0-85105526114 04/30/2021       4 Citations
  • Case Series: Development of Polyps as a Late Effect After Total Body Irradiation-based Hematopoietic Cell Transplantation in Children With High-risk Leukemia. (Knight B, Anderson L, Lerner D, Phelan R, Thakar MS) J Pediatr Hematol Oncol 2021 Nov 01;43(8):e1159-e1163 PMID: 33828034 PMCID: PMC8492786 SCOPUS ID: 2-s2.0-85120523873 04/09/2021       2 Citations
  • Immune function in childhood cancer survivors: a Children's Oncology Group review. (Guilcher GMT, Rivard L, Huang JT, Wright NAM, Anderson L, Eissa H, Pelletier W, Ramachandran S, Schechter T, Shah AJ, Wong K, Chow EJ) Lancet Child Adolesc Health 2021 Apr;5(4):284-294 PMID: 33600774 PMCID: PMC8725381 SCOPUS ID: 2-s2.0-85102642258 02/19/2021       21 Citations
  • Sedated Lymphocyte and Stem Cell Collection With Dexmedetomidine (Magner, Kristin; Gedeit, Rainer; Redfern, Wendi; Dziedzic, Rachel; Buchman, Bo; Anderson, Lynnette; Margolis, David; DeVries, Lisa; Meyer, Michael) Critical Care Medicine Magner, Kristin; Gedeit, Rainer; Redfern, Wendi; Dziedzic, Rachel; Buchman, Bo; Anderson, Lynnette; Margolis, David; DeVries, Lisa; Meyer, Michael: Sedated Lymphocyte and Stem Cell Collection With Dexmedetomidine, Critical Care Medicine: January 2021 - Volume 49 - Issue 1 - p 460 doi: 10.1097/01.ccm.0000729596.04184.01 01/01/2021    
  • Developmental differences in health-related quality of life in adolescent and young adult cancer survivors. (Becktell K, Simpson P, Phelan R, Schmidt D, Anderson L, Nichols J, Bingen K) Qual Life Res 2020 Sep;29(9):2435-2444 PMID: 32323061 SCOPUS ID: 2-s2.0-85084090912 04/24/2020       3 Citations
  • Sequential transplantation and implications for clinical management: OLT followed by HCT and consequent RT in a pediatric patient. (Hoogenboom L, Margolis D, Anderson L, Phelan R) Pediatr Transplant 2019 May;23(3):e13370 PMID: 30779289 SCOPUS ID: 2-s2.0-85061909142 02/20/2019    
  • Efficacy and safety of ruzasvir 60 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4 or 6 infection. (Lawitz E, Poordad F, Anderson LJ, Vesay M, Kelly MM, Liu H, Gao W, Fernsler D, Asante-Appiah E, Robertson MN, Hanna GJ, Barr E, Butterton J, Kowdley KV, Hassanein T, Sahota A, Gordon SC, Yeh WW) J Viral Hepat 2019 Jun;26(6):675-684 PMID: 30739366 SCOPUS ID: 2-s2.0-85062788122 02/11/2019       4 Citations
  • Assessment of end-of-treatment transition needs for pediatric cancer and hematopoietic stem cell transplant patients and their families. (Karst JS, Hoag JA, Chan SF, Schmidt DJ, Anderson LJ, Englebert NE, Igler EC, Bingen KM) Pediatr Blood Cancer 2018 Aug;65(8):e27109 PMID: 29697192 SCOPUS ID: 2-s2.0-85046037124 04/27/2018       20 Citations
  • Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report. (Chow EJ, Anderson L, Baker KS, Bhatia S, Guilcher GM, Huang JT, Pelletier W, Perkins JL, Rivard LS, Schechter T, Shah AJ, Wilson KD, Wong K, Grewal SS, Armenian SH, Meacham LR, Mulrooney DA, Castellino SM) Biol Blood Marrow Transplant 2016 May;22(5):782-95 PMID: 26802323 PMCID: PMC4826622 SCOPUS ID: 2-s2.0-84963656324 01/24/2016       143 Citations
  • A multimethod assessment of psychosocial functioning and late effects in survivors of childhood cancer and hematopoietic cell transplant. (Bingen K, Schroedl RL, Anderson L, Schmidt D, Hoag J, Christiansen H, Kupst MJ) J Pediatr Hematol Oncol 2012 Jan;34(1):22-8 PMID: 22082747 SCOPUS ID: 2-s2.0-84855444794 11/16/2011       9 Citations
  • Late effects in adult survivors of childhood cancer: considerations for the general practitioner. (Schmidt D, Anderson L, Bingen K, Hoag J, Kupst MJ, Warwick AB) WMJ 2010 Apr;109(2):98-107 PMID: 20443329 SCOPUS ID: 2-s2.0-77952373707 05/07/2010       13 Citations
  • Focal nodular hyperplasia in pediatric allogeneic hematopoietic cell transplant: case series. (Anderson L, Gregg D, Margolis D, Casper J, Talano J) Bone Marrow Transplant 2010 Aug;45(8):1357-9 PMID: 20140023 SCOPUS ID: 2-s2.0-77955561931 02/09/2010       20 Citations
  • Growth velocity in pediatric bone marrow transplantation: significance of donor type and treatment factors. (Anderson L, Schmidt D, Bingen K, Kupst MJ, Warwick A) J Pediatr Oncol Nurs 2009;26(6):377-82 PMID: 20032299 SCOPUS ID: 2-s2.0-73249135212 12/25/2009       4 Citations
    • Last update: 05/13/2024